Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.

International journal of oncology

Volumn 20, Issue 4, 2002, Pages 753-759

  Swamy, Malisetty V ^a   Cooma, Indranie ^a   Reddy, Bandaru S ^a   Rao, Chinthalapally V ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CELECOXIB; CYTOCHROME C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMIN; LAMIN B; MEVINOLIN; NUCLEAR PROTEIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN; PYRAZOLE DERIVATIVE; SULFONAMIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; COLON TUMOR; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; MITOCHONDRION;

APOPTOSIS; CASPASE 3; CASPASES; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; CYTOCHROME C GROUP; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LAMIN TYPE B; LAMINS; LOVASTATIN; MITOCHONDRIA; NUCLEAR PROTEINS; PROTEINS; PYRAZOLES; SULFONAMIDES; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0036546112     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.20.4.753     Document Type: Article

References (0)